Holistic Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$679K Buy
738
+60
+9% +$60.8K 0.14% 145
2025
Q4
$729K Buy
678
+80
+13% +$76.5K 0.16% 124
2025
Q3
$457K Buy
598
+84
+16% +$62.5K 0.12% 137
2025
Q2
$401K Buy
514
+227
+79% +$176K 0.11% 143
2025
Q1
$237K Buy
+287
New +$239K 0.08% 166
2024
Q4
Sell
-249
Closed -$221K 177
2024
Q3
$221K Sell
249
-19
-7% -$17.1K 0.09% 142
2024
Q2
$208K Hold
268
0.16% 111
2024
Q1
$208K Buy
+268
New +$191K 0.16% 112

Other funds holding LLY

Holistic Planning's LLY Position: Q1 2026 in Review

Holistic Planning increased its Eli Lilly (LLY) stake by 8.8% in Q1 2026, buying an estimated $60.8K and bringing the position to 738 shares worth $679K. The position accounts for 0.14% of the portfolio, ranked #145.

Holistic Planning first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. The position peaked at $729K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Holistic Planning held 738 shares of Eli Lilly worth $679K as of Q1 2026.
  • Holistic Planning bought 60 Eli Lilly shares in Q1 2026, an estimated $60.8K.
  • Eli Lilly made up 0.14% of Holistic Planning's portfolio in Q1 2026, its #145 holding.
  • Holistic Planning first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • Holistic Planning's Eli Lilly position peaked at $729K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Holistic Planning's 13F filing for Q1 2026, filed 4 May 2026.